Literature DB >> 19880300

T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.

E D Austin1, M T Rock, C A Mosse, C L Vnencak-Jones, S M Yoder, I M Robbins, J E Loyd, B O Meyrick.   

Abstract

RATIONALE: Mounting data suggest that immune cell abnormalities participate in the pathogenesis of pulmonary arterial hypertension (PAH).
OBJECTIVE: To determine whether the T lymphocyte subset composition in the systemic circulation and peripheral lung is altered in PAH.
METHODS: Flow cytometric analyses were performed to determine the phenotypic profile of peripheral blood lymphocytes in idiopathic PAH (IPAH) patients (n=18) and healthy controls (n=17). Immunocytochemical analyses of lymphocytes and T cell subsets were used to examine lung tissue from PAH patients (n=11) and controls (n=11).
MEASUREMENTS AND MAIN RESULTS: IPAH patients have abnormal CD8+ T lymphocyte subsets, with a significant increase in CD45RA+ CCR7- peripheral cytotoxic effector-memory cells (p=0.02) and reduction of CD45RA+ CCR7+ naive CD8+ cells versus controls (p=0.001). Further, IPAH patients have a higher proportion of circulating regulatory T cells (T(reg)) and 4-fold increases in the number of CD3+ and CD8+ cells in the peripheral lung compared with controls (p<0.01).
CONCLUSIONS: Alterations in circulating T cell subsets, particularly CD8+ T lymphocytes and CD4+ T(reg), in patients with PAH suggest that a dysfunctional immune system contributes to disease pathogenesis. A preponderance of CD3+ and CD8+ T lymphocytes in the peripheral lung of PAH patients supports this concept. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19880300      PMCID: PMC2826574          DOI: 10.1016/j.rmed.2009.10.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  44 in total

Review 1.  Arrested differentiation, the self-renewing memory lymphocyte, and vaccination.

Authors:  D T Fearon; P Manders; S D Wagner
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

Review 2.  Clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Nazzareno Galiè; Lewis J Rubin; David Langleben; Werner Seeger; Guido Domenighetti; Simon Gibbs; Didier Lebrec; Rudolf Speich; Maurice Beghetti; Stuart Rich; Alfred Fishman
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

3.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Authors:  R M Tuder; B Groves; D B Badesch; N F Voelkel
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

4.  Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.

Authors:  P Lesprit; B Godeau; F J Authier; M Soubrier; M Zuber; C Larroche; J P Viard; B Wechsler; R Gherardi
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

5.  Chemokine RANTES in severe pulmonary arterial hypertension.

Authors:  Peter Dorfmüller; Véronique Zarka; Ingrid Durand-Gasselin; Gianpaola Monti; Karl Balabanian; Gilles Garcia; Frédérique Capron; Aurore Coulomb-Lherminé; Anne Marfaing-Koka; Gérald Simonneau; Dominique Emilie; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

6.  Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections.

Authors:  Kenneth H Ely; Linda S Cauley; Alan D Roberts; Jean W Brennan; Tres Cookenham; David L Woodland
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells.

Authors:  W Luttmann; V Herzog; J C Virchow; H Matthys; K H Thierauch; C Kroegel
Journal:  Pulm Pharmacol       Date:  1996-02

8.  Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells.

Authors:  C R Valeri; L E Pivacek
Journal:  Transfusion       Date:  1996-04       Impact factor: 3.157

9.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

Authors:  M Humbert; G Monti; F Brenot; O Sitbon; A Portier; L Grangeot-Keros; P Duroux; P Galanaud; G Simonneau; D Emilie
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

Review 10.  Inflammation in pulmonary arterial hypertension.

Authors:  P Dorfmüller; F Perros; K Balabanian; M Humbert
Journal:  Eur Respir J       Date:  2003-08       Impact factor: 16.671

View more
  37 in total

1.  Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.

Authors:  Yoshiharu Sada; Yoshihiro Dohi; Sayuri Uga; Akifumi Higashi; Hiroki Kinoshita; Yasuki Kihara
Journal:  Heart Vessels       Date:  2015-08-29       Impact factor: 2.037

2.  Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.

Authors:  Michael G Risbano; Christina A Meadows; Christopher D Coldren; Tiffany J Jenkins; Michael G Edwards; David Collier; Wendy Huber; Douglas G Mack; Andrew P Fontenot; Mark W Geraci; Todd M Bull
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

Review 3.  Inflammation in Pulmonary Arterial Hypertension.

Authors:  Timothy Klouda; Ke Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.

Authors:  Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 5.  Regulatory T cells and pulmonary hypertension.

Authors:  Rasa Tamosiuniene; Mark R Nicolls
Journal:  Trends Cardiovasc Med       Date:  2011-08       Impact factor: 6.677

6.  Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension.

Authors:  Michael E Yeager; Cecilia M Nguyen; Dmitry D Belchenko; Kelley L Colvin; Shinichi Takatsuki; D Dunbar Ivy; Kurt R Stenmark
Journal:  Chest       Date:  2011-09-22       Impact factor: 9.410

7.  Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.

Authors:  Monal Patel; Dan Predescu; Cristina Bardita; Jiwang Chen; Niranjan Jeganathan; Melanie Pritchard; Salvatore DiBartolo; Roberto Machado; Sanda Predescu
Journal:  Am J Pathol       Date:  2017-01-06       Impact factor: 4.307

8.  Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension.

Authors:  Jennifer E Pogoriler; Stuart Rich; Stephen L Archer; Aliya N Husain
Journal:  Histopathology       Date:  2012-10       Impact factor: 5.087

9.  Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

Authors:  Rasa Tamosiuniene; Wen Tian; Gundeep Dhillon; Lijuan Wang; Yon K Sung; Lajos Gera; Andrew J Patterson; Rani Agrawal; Marlene Rabinovitch; Kelly Ambler; Carlin S Long; Norbert F Voelkel; Mark R Nicolls
Journal:  Circ Res       Date:  2011-08-25       Impact factor: 17.367

10.  Association between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) study.

Authors:  Niu Tian; Alan D Penman; Anthony R Mawson; R Davis Manning; Michael F Flessner
Journal:  J Am Soc Hypertens       Date:  2010-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.